First Trust Advisors LP Cor Medix Inc. Transaction History
First Trust Advisors LP
- $127 Billion
- Q3 2025
A detailed history of First Trust Advisors LP transactions in Cor Medix Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 14,526 shares of CRMD stock, worth $164,724. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,526
Previous 11,557
25.69%
Holding current value
$164,724
Previous $142,000
21.83%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CRMD
# of Institutions
204Shares Held
41.2MCall Options Held
1.33MPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA3.98MShares$45.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$40.3 Million0.0% of portfolio
-
Marshall Wace, LLP London, X03.47MShares$39.4 Million0.05% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.32MShares$37.7 Million0.74% of portfolio
-
State Street Corp Boston, MA1.84MShares$20.8 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $467M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...